Coronavirus survivors are emerging from their illness with powerful antibodies in demand by researchers and physicians across the world. Multiple trials are underway in the U.S., Canada and Europe in the hopes of harnessing the protective powers of antibodies for convalescent plasma that could benefit sick patients or front-line workers.
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.